We are live on
!
Find out more
BOCH
Blue Owl Capital Holdings Portfolio holdings
AUM
$372M
1-Year Est. Return
78.25%
This Fund
S&P 500
This Quarter
Est. Return
+19.21%
1 Year Est. Return
+78.25%
3 Year Est. Return
+112.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$324M
AUM Growth
+$1.9M
(+0.59%)
Cap. Flow
-$30.9M
Cap. Flow
% of AUM
-9.55%
Top 10 Holdings %
Top 10 Hldgs %
61.81%
Holding
89
New
17
Increased
17
Reduced
13
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procore
PCOR
|
+$6.97M |
| 2 |
Oric Pharmaceuticals
ORIC
|
+$5.93M |
| 3 |
MPLT
MapLight Therapeutics
MPLT
|
+$5.48M |
| 4 |
Payoneer
PAYO
|
+$4.81M |
| 5 |
LENZ
LENZ Therapeutics
LENZ
|
+$4.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EverCommerce
EVCM
|
+$18.3M |
| 2 |
Roivant Sciences
ROIV
|
+$14.3M |
| 3 |
Nuveen Churchill Direct Lending
NCDL
|
+$13.5M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
+$6.9M |
| 5 |
Disc Medicine
IRON
|
+$6.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 63.81% |
| 2 | Financials | 18.18% |
| 3 | Technology | 8.81% |
| 4 | Consumer Discretionary | 7.9% |
| 5 | Energy | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XBPEW
76
XBP Europe Holdings Warrant
XBPEW
| $743 | ﹤0.01% |
24,778
| – | – |
|
77
CXApp Inc Warrant
CXAIW
$955K
| $625 | ﹤0.01% |
+12,500
| New | +$990 |
|
|
SLXNW
78
Silexion Therapeutics Warrant
SLXNW
$130K
| $375 | ﹤0.01% |
+12,500
| New | +$444 |
|
|
ACLX
79
DELISTED
Arcellx
ACLX
| – | – |
-26,823
| Closed | -$2.2M |
|
|
80
EverCommerce
EVCM
$1.88B
| – | – |
-1,641,929
| Closed | -$18.3M |
|
81
GitLab
GTLB
$6.87B
| – | – |
-12,352
| Closed | -$557K |
|
|
82
Disc Medicine
IRON
$2.99B
| – | – |
-102,260
| Closed | -$6.76M |
|
|
KPLTW
83
DELISTED
Katapult Holdings Warrant
KPLTW
| $0 | ﹤0.01% |
400,000
| – | – |
|
84
Korro Bio
KRRO
$200M
| – | – |
-105,000
| Closed | -$5.03M |
|
|
MREO
85
Mereo BioPharma
MREO
$45.5M
| – | – |
-1,250,000
| Closed | -$2.58M |
|
86
Tango Therapeutics
TNGX
$4.39B
| – | – |
-119,416
| Closed | -$1M |
|
|
VRNA
87
DELISTED
Verona Pharma
VRNA
| – | – |
-18,347
| Closed | -$98 |
|
|
CEROW
88
DELISTED
CERo Therapeutics Warrants
CEROW
| – | – |
-224,930
| Closed | -$2.99K |
|
|
BLNE
89
Beeline Holdings
BLNE
$34.5M
| $0 | ﹤0.01% |
+129,529
| New | +$314K |
|
Similar funds
PC
GIP
DPCM
SAAM
KP
TCM
JC
HPC
Blue Owl Capital Holdings's Q4 2025 Portfolio in Review
As of Q4 2025, Blue Owl Capital Holdings held 89 positions worth $324M, up 0.59% from $322M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Blue Owl Capital Holdings withdrew a net $30.9M in Q4 2025, closing 9 positions and reducing 13 holdings. Its most notable exit was EverCommerce, an estimated $18.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 57% a quarter earlier, followed by Financials and Technology.
Against the trend, Blue Owl Capital Holdings opened a new position in Procore worth $6.86M.
- Blue Owl Capital Holdings's largest Q4 2025 buy was Procore: 94,264 shares worth $6.86M.
- Blue Owl Capital Holdings added most to Compass Therapeutics in Q4 2025, an estimated $4.04M increase.
- Blue Owl Capital Holdings's biggest Q4 2025 reduction was Roivant Sciences, cutting an estimated $14.3M.
- Blue Owl Capital Holdings fully exited EverCommerce in Q4 2025, selling an estimated $18.3M.
- Blue Owl Capital Holdings's ten largest holdings make up 62% of its $324M portfolio in Q4 2025.
- Blue Owl Capital Holdings opened 17 new positions and closed 9 in Q4 2025.
- Blue Owl Capital Holdings's portfolio value rose 0.59% quarter-over-quarter to $324M.
Based on Blue Owl Capital Holdings's 13F filing for Q4 2025, filed 9 Feb 2026.